Pak Fah Yeow International Limited (0239.HK)

HKD 2.27

(-1.3%)

Net Income Summary of Pak Fah Yeow International Limited

  • Pak Fah Yeow International Limited's latest annual net income in 2023 was 105.03 Million HKD , up 250.66% from previous year.
  • Pak Fah Yeow International Limited's latest quarterly net income in 2024 Q2 was 47.4 Million HKD , down 0.0% from previous quarter.
  • Pak Fah Yeow International Limited reported an annual net income of 29.95 Million HKD in 2022, down -21.56% from previous year.
  • Pak Fah Yeow International Limited reported an annual net income of 38.18 Million HKD in 2021, up 199.56% from previous year.
  • Pak Fah Yeow International Limited reported a quarterly net income of 105.03 Million HKD for 2023 FY, up 250.66% from previous quarter.
  • Pak Fah Yeow International Limited reported a quarterly net income of 49.04 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Pak Fah Yeow International Limited (2023 - 1999)

Historical Annual Net Income of Pak Fah Yeow International Limited (2023 - 1999)

Year Net Income Net Income Growth
2023 105.03 Million HKD 250.66%
2022 29.95 Million HKD -21.56%
2021 38.18 Million HKD 199.56%
2020 -38.35 Million HKD -206.41%
2019 36.04 Million HKD -3.31%
2018 37.28 Million HKD -63.66%
2017 102.58 Million HKD 67.63%
2016 61.19 Million HKD 0.3%
2015 61.01 Million HKD -58.34%
2014 146.46 Million HKD 106.64%
2013 70.88 Million HKD 10.16%
2012 64.34 Million HKD 39.19%
2011 46.22 Million HKD -15.97%
2010 55.01 Million HKD -7.65%
2009 59.56 Million HKD 427.49%
2008 -18.18 Million HKD -150.52%
2007 36 Million HKD -14.47%
2006 42.09 Million HKD 25.16%
2005 33.63 Million HKD -22.98%
2004 43.66 Million HKD 31.43%
2003 33.22 Million HKD 92.26%
2002 17.28 Million HKD 530.23%
2001 2.74 Million HKD -88.47%
2000 23.78 Million HKD -4.46%
1999 24.89 Million HKD 0.0%

Peer Net Income Comparison of Pak Fah Yeow International Limited

Name Net Income Net Income Difference
Grand Pharmaceutical Group Limited 1.87 Billion HKD 94.413%
Extrawell Pharmaceutical Holdings Limited -162.94 Million HKD 164.461%
Wai Yuen Tong Medicine Holdings Limited -15.35 Million HKD 784.026%
Qianhai Health Holdings Limited -52.7 Million HKD 299.296%
Lee's Pharmaceutical Holdings Limited 16.69 Million HKD -529.051%
Essex Bio-Technology Limited 275.25 Million HKD 61.84%
Tongfang Kontafarma Holdings Limited -28.84 Million HKD 464.175%
PuraPharm Corporation Limited -106.08 Million HKD 199.018%
SSY Group Limited 1.31 Billion HKD 92.034%
JBM (Healthcare) Limited 130.46 Million HKD 19.488%
Jacobson Pharma Corporation Limited 266.96 Million HKD 60.655%
China Resources Pharmaceutical Group Limited 3.85 Billion HKD 97.275%